Skip Navigation

The event ended, check back after it has been posted to the Past Events section.

Is the Right Flavor of Inflammation the Key to Successful Cancer Therapy?HHS Only

Air date: Friday, January 27, 2017, 12:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Description: NCI’s Center for Cancer Research (CCR) Grand Rounds

Dr. Romina Goldszmid received her Ph.D. working on dendritic cell-based vaccines for melanoma immunotherapy from the University of Buenos Aires, Argentina, part of which was performed as a visiting scholar in the laboratory of Dr. Ralph Steinman at the Rockefeller University. She then did her postdoctoral training in infectious diseases immunology with Dr. Alan Sher in the Laboratory of Parasitic Diseases (LPD) at NIAID. There, Dr. Goldszmid focused on the interplay between dendritic cells and natural killer cells during the early response to Toxoplasma gondii infection and on the mechanisms underlying antigen presentation of protozoan parasites in dendritic cells. In 2009, Dr. Goldszmid returned to tumor immunology, joining Dr. Giorgio Trinchieri's laboratory at NCI as a Staff Scientist. While there, she studied the role of the gut microbiota in regulating the response to cancer therapy. She is now an NIH Earl Stadtman Investigator in CCR’s Cancer and Inflammation Program and an Adjunct Investigator in the LPD, NIAID. Her research focuses on the role of the microbiome in various aspects of cancer and infectious diseases, with the ultimate goal of identifying new potential therapeutic interventions for both.
Author: Romina Goldszmid, Ph.D., Earl Stadtman Investigator, Cancer and Inflammation Program, Center for Cancer Research, NCI, NIH
Runtime: 1 hour